G01N 2333/524
Thrombopoietin, i.e. c-mpl ligand
Official title: Thrombopoietin, i.e. C-MPL ligand
G01N2333/524 (Thrombopoietin, i.e. c-mpl ligand) appears on 0 US grants and 4 published applications in this corpus.
Search patents in G01N- Granted patents
- 0
- Published applications
- 4
- Assignees
- 3
- Inventors
- 10
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Blood Test to Screen Out Parkinson's Disease18 Jul 2024US 2024/0241138 A1University of North Texas Health Science Center at Fort Worth
- Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury21 Aug 2014US 2014/0234322 A1University of Rochester
- Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury13 Feb 2014US 2014/0047572 A1University of Rochester
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure5 Sep 2013US 2013/0230871 A1Astute Medical, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.